Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison.
Philip D HomeRoopa MehtaKhadija A S HafidhOlesya Y GurovaAgustina AlvarezPaul SerafiniMir-Masoud PourrahmatPublished in: Diabetes, obesity & metabolism (2021)
iGlarLixi appears to offer clinical benefit in glucose control and bodyweight change in people needing both basal and meal-time intervention.